Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Sangamo Therapeutics Enters into Agreement with Lilly Sign for Gene Therapy in Neurological Diseases
Friday, April 04, 2025Sangamo Therapeutics has entered into a licence agreement with Eli Lilly and Company Lilly to support the development of genomic medicines for central nervous system CNS disorders The agreement grants Lilly global exclusive rights to use Sangamos neu...
Novartis Secures FDA Approval for Vanrafia® to Treat Primary IgA Nephropathy
Thursday, April 03, 2025Novartis has received accelerated approval from the US Food and Drug Administration FDA for Vanrafia atrasentan a selective endothelin A ETA receptor antagonist for reducing proteinuria in adults with primary immunoglobulin A nephropathy IgAN who are...
Flagship Pioneering and Pfizer Partner to Develop Novel Autoimmune Disease Treatments
Thursday, April 03, 2025Flagship Pioneering has announced a collaboration between its drug discovery division Pioneering Medicines and Pfizer to identify potential small molecule inhibitors for autoimmune diseases As part of the agreement Charles River will utilise Logica a...
Astellas Enters into Collaboration with Japanese Foundation for Cancer Research to Advance Oncology Research
Wednesday, April 02, 2025Astellas Pharma and the Japanese Foundation for Cancer Research JFCR have entered into a strategic collaboration to accelerate translational and clinical oncology research
Ono Enters into Collaboration with Reborna Biosciences for RNA-Targeting Neurological Drug Discovery
Tuesday, April 01, 2025Ono Pharmaceutical has entered into a drug discovery collaboration with Reborna Biosciences to develop novel small molecules targeting ribonucleic acid RNA for the treatment of central nervous system disorders
Alnylam Pharmaceuticals Secures Approval for Qfitlia™ (Fitusiran siRNA Therapy for Haemophilia A and B
Saturday, March 29, 2025Alnylam Pharmaceuticals has received approval from the United States Food and Drug Administration FDA for Qfitlia fitusiran the first small interfering RNA siRNA therapy for treating haemophilia A or B
IASO Bio Secures NDA Approval on Equecabtagene Autoleucel for Multiple Myeloma in Macau
Friday, March 28, 2025IASO Biotherapeutics has received approval from the Pharmaceutical Administration Bureau of the Macao Special Administrative Region ISAF for the New Drug Application NDA of Equecabtagene Autoleucel
Zenyaku Kogyo and Chugai’s Rituxan® Gains Approval for Treating Relapsing or Steroid-Dependent Nephrotic Syndrome
Friday, March 28, 2025Zenyaku Kogyo and Chugai Pharmaceutical have announced that Japans Ministry of Health Labour and Welfare MHLW has approved an additional indication for the antiCD monoclonal antibody Rituxan rituximab
Junshi Biosciences Secures Approval for Toripalimab (LOQTORZI®) for Nasopharyngeal Carcinoma
Thursday, March 27, 2025Junshi Biosciences has received approval from the Singapore Health Sciences Authority HSA for toripalimab marketed as LOQTORZI in Singapore Nasopharyngeal carcinoma is a malignant tumour that originates in the epithelial mucosa of the nasopharynx and...
Exelixis Secures FDA Approval for CABOMETYX® in Advanced Neuroendocrine Tumours
Thursday, March 27, 2025Exelixis has announced that the United States Food and Drug Administration FDA has approved CABOMETYX cabozantinib for the treatment of adult and paediatric patients aged years and older with previously treated unresectable
